#ProstateCancerCVDRisk

Cardiovascular outcomes among patients with castration-resistant prostate cancer: A comparative safety study using U.S. administrative claims data

• Analytics use case(s): Estimation (Comparative Cohort), Characterization
• Study type: Clinical Research
• Tags: prostate cancer, castration-resistant prostate cancer, antiandrogens, aberaterone, enzalutamide, cardiovascular, safety, heart failure, acute myocardial infarction, ischemic stroke
• Study lead: Mitchell M. Conover
• Study lead forums tag: [conovermitch]
• Study start date: 11/27/2019
• Study end date: 8/1/2021
• Publications: TBD
• Results explorer: -

This repository contains study specification and documentation for a comparative cohort study comparing initiators aberaterone and enzalutamide with respect to incidence of various cardiovascular safety events including heart failure, acute myocardial infarction, and ischemic stroke.